Poly Medicure Ltd.

BSE: 532540 NSE: Poly Medicure ISIN:  INE467B01029 SECTOR: IT Software Company Company’s Website: IPO Date & Price: July 29, 2004 | Rs.

Poly Medicure Overview:

Stock Symbol in NSEStock Symbol in BSECurrent PriceMarket Cap. (Cr)P/E RatioCurrent EPS
About

Poly Medicure

Its the Indian No-1 multinational information service and consulting Provider company. Poly Medicure is the Subsidiary Company of TATA Group and it’s founded in 1968.

Poly Medicure Sector Performance and Peer Comparison with Sector Analysis:

Did You Know?

<Space for Feature Image>

  • Poly Medicure is the
  • Its Belong to Group.

Balance Sheets & Profit & Loss Account:

YearMar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020

Poly Medicure Share Price Forecast Based on Current Growth +5/-5:

Share Price and EPS Forecast Based on Current Average Growth Rates:

Next 5 Years (CG)Next 10 Years (CG)Next 20 Years (CG)

Share Price and EPS Forecast Based on Current Average Growth Rates Plus 5%:

Next 5 Years (CG+5%)Next 10 Years (CG+5%)Next 20 Years (CG+5%)

Share Price and EPS Forecast Based on Current Average Growth Rates Minus 5%:

Next 5 Years (CG-5%)Next 10 Years (CG-5%)Next 20 Years (CG-5%)

Poly Medicure Quarterly Result, Date & Street Estimate:

Share NameQuarter ResultsYearStreet EstimatesProfitsGrowth

Fundamental Analysis of Poly Medicure :

Poly Medicure Share Long Term Investment Price Target:

PriceLong Term Investment TagetsQnt.Ratio

Poly Medicure Fundamentals SWAT Analysis by AMT

 Strengths, Weaknesses, Opportunities, and Threats of Poly Medicure

S

  • Strengths Analysis will coming Soon.

W

  • Weakness Analysis will coming Soon.

O

  • Opportunity Analysis will coming Soon.

T

  • Threats Analysis will coming Soon.

Where we can See Poly Medicure in Next 5 Year, 10 Year & 20 Year?

Technical Analysis of Poly Medicure :

Poly Medicure Share Weekly Swing Trading Price Target:

Demand And Supply ZoneSupport LevelsSupport PriceResistance LevelsResistance Price

Poly Medicure Share Today Intraday Price Target:

IntradayTarget Today [Short Selling]IntradayTarget Today [Long Buying]

FAQ on Poly Medicure :

Is it Good to Buy Poly Medicure Share?

Yes, Poly Medicure is India Number-1 IT Software company, with lots business potential in next few year. Its Fundamentally strong Stock we recommend to buy at around 20-25 PE Ration price target. Anyway This company is quite famous for Good Dividends.

Is Poly Medicure Debt Free Company?

Poly Medicure is a Debt free company. Its can easily survived any down turn for 5-10 Quarter business growth.

Is Poly Medicure Overvalued?

Currently Poly Medicure is Trading at P/E Ratio which is

Is Poly Medicure Better than Infosys?

Both and working as a

Why Poly Medicure Share Price is Falling?

Do to Covid-19 pandemic Poly Medicure Share drastically fall.

Why Poly Medicure Share Price is Going Up?

Is Poly Medicure Good for Long Term Investment?

Its depend on when you and at what price you have buy this share, Poly Medicure at 20-25 P/E Ration is a excellent buy call for long Term Investment.

Poly Medicure ‘s Products/Projects:

Products/ProjectsDescription/Valuation
A.
B.
C.

IPO, Split, Bonus, Dividend Buyback History:

Poly Medicure First IPO was initiate on July 29, 2004. equity shares were put on sale during the IPO with a price band of Rs -Rs per equity share.

[ninja_tables id=”81455″

Company Profile:

CEO NameHimanshu Baid
CFO NameJ K Oswal
CEO Salary
35Million
Company Address232 B, 3rd Floor, Okhla Industrial Area Phase 3, New Delhi, 110020
Contact Number26321838, 26321881, 26321889, 26321893
Email AddressInvestorcare@polymedicure.com polymed.eu@polymedicure.com

Declaration: Investing in the Stock market is full of Risky. AllMoneyTips.COM doesn’t give any guarantee or warranted on its investment advice. Do your research before investing in the stock market. Our Forecast and buying selling levels of stocks is based on price action and demand and supply zone. There is no guarantee come with our prediction. Take it as advice only. We are not responsible for your losses on your investments.